{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:21:50Z","timestamp":1787185310468,"version":"build-2736575974"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","award":["JLSWSRCZX2020-0018"],"award-info":[{"award-number":["JLSWSRCZX2020-0018"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","award":["JLSWSRCZX2021-0076"],"award-info":[{"award-number":["JLSWSRCZX2021-0076"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20190303181SF"],"award-info":[{"award-number":["20190303181SF"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopha.2022.113936","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T20:12:58Z","timestamp":1667247178000},"page":"113936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review"],"prefix":"10.1016","volume":"156","author":[{"given":"Ruqing","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongzhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-fan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102993","article-title":"Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge","volume":"21","author":"Merlonghi","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.biopha.2022.113936_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients[J]","volume":"101","author":"Betteridge","year":"2019","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nmd.2006.03.002","article-title":"Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)[J]","volume":"16","author":"Arlet","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.biopha.2022.113936_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.777502","article-title":"Belimumab for immune-mediated necrotizing myopathy associated with anti-SRP antibodies: a case report and retrospective review of patients treated with anti-b-cell therapy in a single center and literature","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Immunol."},{"issue":"5885","key":"10.1016\/j.biopha.2022.113936_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/299691a0","article-title":"Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum","volume":"299","author":"Walter","year":"1982","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.biopha.2022.113936_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1802252115","article-title":"Sequential activation of human signal recognition particle by the ribosome and signal sequence drives efficient protein targeting","volume":"115","author":"Lee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2958.2004.04139.x","article-title":"A structural step into the SRP cycle","volume":"53","author":"Wild","year":"2004","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/bi0353777","article-title":"Signal recognition particle Alu domain occupies a defined site at the ribosomal subunit interface upon signal sequence recognition","volume":"43","author":"Terzi","year":"2004","journal-title":"Biochemistry"},{"issue":"6809","key":"10.1016\/j.biopha.2022.113936_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/35041507","article-title":"Structure and assembly of the Alu domain of the mammalian signal recognition particle","volume":"408","author":"Weichenrieder","year":"2000","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.biopha.2022.113936_bib13","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1093\/emboj\/cdg337","article-title":"Structure, function and evolution of the signal recognition particle","volume":"22","author":"Nagai","year":"2003","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.biopha.2022.113936_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073773","article-title":"Targeting of proteins for translocation at the endoplasmic reticulum","volume":"23","author":"Pool","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7297","key":"10.1016\/j.biopha.2022.113936_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature08870","article-title":"Recognition of a signal peptide by the signal recognition particle","volume":"465","author":"Janda","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib16","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar1895","article-title":"Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages","volume":"8","author":"R\u00f6misch","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2022.113936_bib17","first-page":"17","article-title":"SRP-mediated protein targeting: structure and function revisited","volume":"1694","author":"Luirink","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0854.2011.01171.x","article-title":"Molecular mechanism of co-translational protein targeting by the signal recognition particle","volume":"12","author":"Saraogi","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.biopha.2022.113936_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1146\/annurev.biochem.70.1.755","article-title":"The signal recognition particle","volume":"70","author":"Keenan","year":"2001","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0955-0674(96)80027-5","article-title":"Approaching the mechanism of protein transport across the ER membrane","volume":"8","author":"Rapoport","year":"1996","journal-title":"Curr. Opin. Cell Biol."},{"issue":"13","key":"10.1016\/j.biopha.2022.113936_bib21","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1002\/j.1460-2075.1990.tb07902.x","article-title":"The methionine-rich domain of the 54 kd protein subunit of the signal recognition particle contains an RNA binding site and can be crosslinked to a signal sequence","volume":"9","author":"Zopf","year":"1990","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1083\/jcb.113.2.229","article-title":"The signal sequence interacts with the methionine-rich domain of the 54-kD protein of signal recognition particle","volume":"113","author":"High","year":"1991","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/cdd.2009.197","article-title":"Granzyme B cleavage of autoantigens in autoimmunity","volume":"17","author":"Darrah","year":"2010","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","article-title":"Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease","volume":"73","author":"Sordet","year":"2006","journal-title":"Jt. Bone Spine"},{"issue":"8","key":"10.1016\/j.biopha.2022.113936_bib26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.40883","article-title":"Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity","volume":"71","author":"Pinal-Fernandez","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.190.6.815","article-title":"Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity","volume":"190","author":"Casciola-Rosen","year":"1999","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.biopha.2022.113936_bib28","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/art.22870","article-title":"T cell epitopes of the La\/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301\/DQB1*0201","volume":"56","author":"Dudek","year":"2007","journal-title":"Arthritis Rheumatol."},{"issue":"24","key":"10.1016\/j.biopha.2022.113936_bib29","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2022.113936_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib32","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP(+) and anti-HMGCR(+)myopathies: Role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.biopha.2022.113936_bib33","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2022.113936_bib34","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib35","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/rheumatology\/keab629","article-title":"Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series","volume":"61","author":"Zhang","year":"2022","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jca.21968","article-title":"Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy","volume":"37","author":"Kruse","year":"2022","journal-title":"J. Clin. Apher."},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12772","article-title":"Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies","volume":"30","author":"Fischer","year":"2020","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2022.113936_bib39","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3389\/fphys.2020.00988","article-title":"Isoquercitrin delays denervated soleus muscle atrophy by inhibiting oxidative stress and inflammation","volume":"11","author":"Shen","year":"2020","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113936_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091327","article-title":"Out of control: the role of the ubiquitin proteasome system in skeletal muscle during inflammation","volume":"11","author":"Haberecht-M\u00fcller","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2022.113936_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-981-15-0602-4_16","article-title":"Autophagy and energy metabolism","volume":"1206","author":"Yang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib42","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2018.09.008","article-title":"Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy","volume":"18","author":"Anquetil","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib45","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","article-title":"IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting","volume":"20","author":"Zhang","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.04-2364com","article-title":"TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2022.113936_bib47","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101096R","article-title":"Fusion and beyond: satellite cell contributions to loading-induced skeletal muscle adaptation","volume":"35","author":"Murach","year":"2021","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1242\/jcs.03371","article-title":"IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes","volume":"120","author":"Jacquemin","year":"2007","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0092-8674(03)00319-2","article-title":"IL-4 acts as a myoblast recruitment factor during mammalian muscle growth","volume":"113","author":"Horsley","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113936_bib50","first-page":"67","article-title":"Skeletal muscle IL-4, IL-4Ralpha, IL-13 and IL-13Ralpha1 expression and response to strength training","volume":"13","author":"Prokopchuk","year":"2007","journal-title":"Exerc. Immunol. Rev."},{"issue":"14","key":"10.1016\/j.biopha.2022.113936_bib51","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/MCB.23.14.4991-5004.2003","article-title":"Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes","volume":"23","author":"Figueroa","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2022.113936_bib52","article-title":"miR-18a-3p and its target protein HuR may regulate myogenic differentiation in immune-mediated necrotizing myopathy","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113936_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2013.08.008","article-title":"Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM)","volume":"264","author":"Rojana-Udomsart","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/annrheumdis-2018-213518","article-title":"In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy","volume":"78","author":"Bergua","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010148","article-title":"Complement as a therapeutic target in systemic autoimmune diseases","volume":"10","author":"Galindo-Izquierdo","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2249.1998.00664.x","article-title":"A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli","volume":"113","author":"Nagaraju","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib58","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113936_bib59","article-title":"The efficacy of tocilizumab in the treatment of patients with refractory immune-mediated necrotizing myopathies: an open-label pilot study","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib60","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113936_bib61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/s40064-016-2197-2","article-title":"Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6","volume":"5","author":"Beliz\u00e1rio","year":"2016","journal-title":"Springerplus"},{"issue":"4","key":"10.1016\/j.biopha.2022.113936_bib62","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and specificity: insights from the interleukin 6 family of cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115327","article-title":"A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors","volume":"28","author":"Kaur","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2022.113936_bib64","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3656","article-title":"STAT3 signaling controls satellite cell expansion and skeletal muscle repair","volume":"20","author":"Tierney","year":"2014","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib65","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-induced skeletal muscle atrophy","volume":"98","author":"Haddad","year":"2005","journal-title":"J. Appl. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113936_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577833","article-title":"Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy","volume":"365","author":"Oda","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113936_bib69","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.molimm.2004.06.041","article-title":"The BAFF\/APRIL system: life beyond B lymphocytes","volume":"42","author":"Ng","year":"2005","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113936_bib70","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.yexcr.2011.02.005","article-title":"BAFF inhibition: a new class of drugs for the treatment of autoimmunity","volume":"317","author":"Liu","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.biopha.2022.113936_bib71","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113936_bib72","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni842","article-title":"BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells","volume":"3","author":"Claudio","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113936_bib73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2017.10.002","article-title":"Signalling for B cell survival","volume":"51","author":"Schweighoffer","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib74","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3899\/jrheum.120555","article-title":"BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies","volume":"40","author":"L\u00f3pez De Padilla","year":"2013","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib75","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13075-014-0454-8","article-title":"Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52\/anti-Ro60 autoantibodies","volume":"16","author":"Kry\u0161t\u016ffkov\u00e1","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib76","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies","volume":"68","author":"Krystufkov\u00e1","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13023-020-01431-7","article-title":"Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies","volume":"15","author":"Zhao","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib78","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10067-018-4046-x","article-title":"Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults[J]","volume":"37","author":"Gupta","year":"2018","journal-title":"Clin. Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib79","article-title":"Belimumab for systemic lupus erythematosus","volume":"2","author":"Singh","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar3791","article-title":"Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies","volume":"14","author":"Coley","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib81","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/BOR.0000000000000212","article-title":"Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies - potential role of ER stress pathways","volume":"27","author":"Lightfoot","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"issue":"11","key":"10.1016\/j.biopha.2022.113936_bib82","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/art.1780341108","article-title":"Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies","volume":"34","author":"Leff","year":"1991","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib83","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5692\/clinicalneurol.cn-001684","article-title":"A case of anti-SRP antibody-positive immune-mediated necrotizing myopathy triggered by human parvovirus B19 infection","volume":"62","author":"Suzuki","year":"2022","journal-title":"Rinsho Shinkeigaku"},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib84","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/BOR.0000000000000652","article-title":"Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis","volume":"31","author":"Rothwell","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113936_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886290","article-title":"The Genetics of Autoimmune Myositis[J]","volume":"13","author":"Lamb","year":"2022","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib86","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/annrheumdis-2018-214127","article-title":"Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases[J]","volume":"78","author":"Acosta-Herrera","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2022.113936_bib87","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","article-title":"Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups[J]","volume":"78","author":"Rothwell","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"18","key":"10.1016\/j.biopha.2022.113936_bib88","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0000000000003160","article-title":"HLA-DRB1 alleles in immune-mediated necrotizing myopathy[J]","volume":"87","author":"Ohnuki","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib89","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semarthrit.2019.03.005","article-title":"Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients[J]","volume":"49","author":"Kang","year":"2019","journal-title":"Semin Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.biopha.2022.113936_bib90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/BOR.0000000000000335","article-title":"Spectrum of immune-mediated necrotizing myopathies and their treatments[J]","volume":"28","author":"Pinal-Fernandez","year":"2016","journal-title":"Curr. Opin. Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies","volume":"85","author":"O'hanlon","year":"2006","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.biopha.2022.113936_bib92","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/art.22205","article-title":"HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies","volume":"54","author":"O'hanlon","year":"2006","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113936_bib93","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","author":"Miller","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"39","key":"10.1016\/j.biopha.2022.113936_bib94","doi-asserted-by":"crossref","first-page":"16899","DOI":"10.1073\/pnas.1009511107","article-title":"Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis","volume":"107","author":"Menconi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib95","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1474-4422(12)70238-7","article-title":"Endoplasmic reticulum dysfunction in neurological disease","volume":"12","author":"Roussel","year":"2013","journal-title":"Lancet Neurol."},{"issue":"6524","key":"10.1016\/j.biopha.2022.113936_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb6896","article-title":"QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis","volume":"371","author":"You","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113936_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.791986","article-title":"Endoplasmic reticulum stress is involved in muscular pathogenesis in idiopathic inflammatory myopathies","volume":"10","author":"Ma","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113936_bib98","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a013169","article-title":"Endoplasmic reticulum stress sensing in the unfolded protein response","volume":"5","author":"Gardner","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113936_bib99","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nri2449","article-title":"Nutrient sensing and inflammation in metabolic diseases","volume":"8","author":"Hotamisligil","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2022.113936_bib100","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1002\/jcp.25785","article-title":"Crosstalk of autophagy and apoptosis: involvement of the dual role of autophagy under ER stress","volume":"232","author":"Song","year":"2017","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.113936_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13084","article-title":"Endoplasmic reticulum-stress and unfolded protein response-activation in immune-mediated necrotizing myopathy","author":"Preusse","year":"2022","journal-title":"Brain Pathol."},{"issue":"13","key":"10.1016\/j.biopha.2022.113936_bib102","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.15252\/embj.201796697","article-title":"Molecular definitions of autophagy and related processes","volume":"36","author":"Galluzzi","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2022.113936_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940122","article-title":"Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?","volume":"13","author":"Corona-Sanchez","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113936_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.793328","article-title":"Selective autophagy receptor p62\/SQSTM1, a pivotal player in stress and aging","volume":"10","author":"Kumar","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113936_bib105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"12","key":"10.1016\/j.biopha.2022.113936_bib106","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113936_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101762","article-title":"Possible future avenues for myositis therapeutics: DM, IMNM and IBM","volume":"36","author":"Connolly","year":"2022","journal-title":"Best Pract. Res. Clin. Rheumatol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222013257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222013257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:06:52Z","timestamp":1778242012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222013257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":107,"alternative-id":["S0753332222013257"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113936","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113936"}}